
Malnutrition in aged care isn’t a fringe concern. Research published in Healthcare (2024) found that up to 40% of older adults living in aged care homes are malnourished.¹ In the community, the figure shifts but doesn’t improve —–up to 60% of older adults living at home are at risk.²
For operators and board members, those figures carry operational weight. Malnutrition is associated with higher infection rates, increased falls and fractures, delayed wound healing, elevated depression risk, and reduced quality of life.² These outcomes create costs across care hours, adverse event reporting, accreditation risk, and resident wellbeing.
Early identification and targeted nutritional support can interrupt that trajectory. The evidence now makes action easier to justify than inaction.
Oral nutrition supplements: compliance matters as much as clinical efficacy
Fortisip® Compact Protein, developed by Nutricia, is an evidence-based oral nutritional supplement (ONS) specifically developed to nutritionally support older adults. As a ready-to-drink nutrition supplement that is high in calories (306kcal), high in protein (18g) and contains vitamins and minerals, it can support older adults going through illness or recovery and struggling to get enough nutrition from food alone. Fortisip® Compact Protein’s convenient low-volume format and wide variety of flavours, help drive greater acceptance and adherence in residential and aged care settings.
Clinical efficacy only translates into outcomes when residents consume it consistently. Nutricia’s convenient low-volume format and wide flavour range help support greater acceptance and adherence, addressing this practical challenge operators know well.
Supporting residents with early Alzheimer’s disease
Souvenaid® occupies a distinctive position in the Australian market. It contains Fortasyn® Connect, a combination of nutrients, formulated to nutritionally support the growth of connections within the brain, known as synapses.⁵ It is currently the only Food for Special Medical Purposes (FSMP) in Australia indicated for the dietary management of early Alzheimer’s disease, including mild cognitive impairment (MCI).
Backed by 20 years of evidence-based research,⁶⁻⁹ Souvenaid® supports memory function in early Alzheimer’s disease when taken daily for at least six months.⁶⁻⁸
For operators managing residents with early Alzheimer’s disease, this specific indication may support an individualised approach to nutritional care planning that is consistent with the person-centred care principles underpinning the Aged Care Act 2024.
Support at Home funding: what operators need to confirm
Both Fortisip® and Souvenaid® are included under the Support at Home program and can be funded where aligned with a client’s identified needs and preferences, when recommended by a treating healthcare professional.
That eligibility is worth checking against your current care planning processes. If nutritional support isn’t being assessed and documented as part of Support at Home goal-setting, clients who could benefit may be missing out — and funding that could reduce downstream care burden may be going unclaimed.
Reducing the burden on your team
Nutricia’s support infrastructure extends beyond the products. Their dedicated aged care team offers education and training in malnutrition screening, nutrition, and early Alzheimer’s disease. The National Nutricia Nurse Service provides specialist support for enterally fed residents and clients. And the Nutricia Careline — staffed by accredited dietitians and nutritionists — is available for expert advice and guidance.
For operators managing workforce constraints and care minutes compliance, having external clinical expertise available is a practical resource, not a nice-to-have.
Take the next step
To discuss how Nutricia’s portfolio and support services could work within your organisation’s nutritional care model, contact the Nutricia Careline on 1800 438 500 or [email protected].
Disclaimer: Souvenaid® and Fortisip® are foods for special medical purposes and must be used under medical supervision.
References:
1. O’Shea M-C, et al. Healthcare. 2024; 12(13):1296.
2. Roberts S, et al. Nutrients. 2021; 13(7):2316.
3. Smith TR, et al. Nutrients. 2020;12(2):517.
4. Grönstedt H, et al. JAMDA. 2020;21(9):1229–1237.
5. Sijben et al. OCL 2011:18;267–270.
6. Scheltens P et al. Alzheimers Dement 2010; 6: 1–10.
7. Scheltens P et al. J Alzheimers Dis 2012; 31: 225–236.
8. Soininen H, et al. Alzheimer’s Dement. 2021;17:29–40. 9. Shah RC et al. Alzheimers Res Ther 2013; 5: 59.